↓ Skip to main content

Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors

Overview of attention for article published in Experimental Hematology & Oncology, December 2021
Altmetric Badge

About this Attention Score

  • Among the highest-scoring outputs from this source (#47 of 298)
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter
10 X users

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
7 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors
Published in
Experimental Hematology & Oncology, December 2021
DOI 10.1186/s40164-021-00251-0
Pubmed ID
Authors

Kyaw Z. Thein, Sarina A. Piha-Paul, Apostolia Tsimberidou, Daniel D. Karp, Filip Janku, Siqing Fu, Vivek Subbiah, David S. Hong, Timothy A. Yap, Jatin Shah, Denái R. Milton, Lacey McQuinn, Jing Gong, Yanyan Tran, Brett W. Carter, Rivka Colen, Funda Meric-Bernstam, Aung Naing

X Demographics

X Demographics

The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 7 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 7 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 2 29%
Student > Doctoral Student 1 14%
Student > Bachelor 1 14%
Unknown 3 43%
Readers by discipline Count As %
Sports and Recreations 2 29%
Agricultural and Biological Sciences 1 14%
Nursing and Health Professions 1 14%
Unknown 3 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 August 2022.
All research outputs
#5,791,624
of 23,041,514 outputs
Outputs from Experimental Hematology & Oncology
#47
of 298 outputs
Outputs of similar age
#127,670
of 502,921 outputs
Outputs of similar age from Experimental Hematology & Oncology
#2
of 6 outputs
Altmetric has tracked 23,041,514 research outputs across all sources so far. This one has received more attention than most of these and is in the 74th percentile.
So far Altmetric has tracked 298 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.9. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 502,921 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.